Kohlberg Kravis Roberts & Co’s Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFNT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,459
Closed -$3K 234
2022
Q2
$3K Hold
12,459
﹤0.01% 237
2022
Q1
$4K Buy
+12,459
New +$5.44K ﹤0.01% 258

Other funds holding NFNT.WS

Kohlberg Kravis Roberts & Co's NFNT.WS Position: Q3 2022 in Review

Kohlberg Kravis Roberts & Co sold out of Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFNT.WS) in Q3 2022, closing a stake of 12,459 shares — an estimated $3K sold.

Kohlberg Kravis Roberts & Co first reported a position in NFNT.WS in Q1 2022 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 40 funds tracked by Wall St. Rank hold NFNT.WS as of Q3 2022.

  • Kohlberg Kravis Roberts & Co reported no remaining Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 12,459 Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $3K.
  • Kohlberg Kravis Roberts & Co first reported a position in Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Kohlberg Kravis Roberts & Co's Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $4K in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2022, filed 14 Nov 2022.